logo
AAT Bioquest

ReadiUse™ Preactivated APC Maleimide [Activated Allophycocyanin]

Flow cytometry analysis of whole blood cells stained with CD8 (SK1)-APC conjugate prepared with ReadiUse™ Preactivated APC Maleimide (Cat No. 2567). The fluorescence signal was monitored using an Aurora spectral flow cytometer in the R1-A channel
Flow cytometry analysis of whole blood cells stained with CD8 (SK1)-APC conjugate prepared with ReadiUse™ Preactivated APC Maleimide (Cat No. 2567). The fluorescence signal was monitored using an Aurora spectral flow cytometer in the R1-A channel
Flow cytometry analysis of whole blood cells stained with CD8 (SK1)-APC conjugate prepared with ReadiUse™ Preactivated APC Maleimide (Cat No. 2567). The fluorescence signal was monitored using an Aurora spectral flow cytometer in the R1-A channel
Ordering information
Price
Catalog Number
Unit Size
Quantity
Add to cart
Additional ordering information
Telephone1-800-990-8053
Fax1-800-609-2943
Emailsales@aatbio.com
InternationalSee distributors
Bulk requestInquire
Custom sizeInquire
ShippingStandard overnight for United States, inquire for international
Request quotation
Physical properties
SolventWater
Spectral properties
Correction Factor (280 nm)0.195
Extinction coefficient (cm -1 M -1)730000
Excitation (nm)651
Emission (nm)660
Storage, safety and handling
H-phraseH303, H313, H333
Hazard symbolXN
Intended useResearch Use Only (RUO)
R-phraseR20, R21, R22
StorageRefrigerated (2-8 °C); Minimize light exposure
UNSPSC12171501
Related products
ReadiUse™ Preactivated APC-iFluor® 700 Tandem
ReadiUse™ Preactivated APC-iFluor® 750 Tandem
ReadiUse™ Preactivated PE-iFluor® 647 Tandem
ReadiUse™ Preactivated PE-iFluor® 750 Tandem
ReadiUse™ ABTS Substrate Solution *Optimized for ELISA Assays with HRP Conjugates*
ReadiUse™ TMB Substrate Solution *Optimized for ELISA Assays with HRP Conjugates*
ReadiUse™ hydrogen peroxide solution *50 mM calibrated and stabilized solution*
ReadiUse™ Preactivated HRP NHS ester
ReadiUse™ NADPH Regenerating Kit
ReadiUse™ NADP Regenerating Kit
ReadiUse™ TCA Deproteinization Sample Preparation Kit
ReadiUse™ microscope mounting solution
ReadiUse™ 4% formaldehyde fixation solution
ReadiUse™ mammalian cell lysis buffer *5X*
ReadiUse™ probenecid, sodium salt *Water-soluble*
ReadiUse™ probenecid *25 mM stabilized aqueous solution*
ReadiUse™ CFSE [5-(and 6)-Carboxyfluorescein diacetate, succinimidyl ester] *CAS 150347-59-4*
ReadiUse™ Preactivated PE
ReadiUse™ Preactivated APC
ReadiUse™ Preactivated PE-Cy5 Tandem
ReadiUse™ Preactivated PE-Cy5.5 Tandem
ReadiUse™ Preactivated PE-Cy7 Tandem
ReadiUse™ Preactivated PE-Texas Red Tandem
ReadiUse™ Preactivated APC-Cy5.5 Tandem
ReadiUse™ Preactivated APC-Cy7 Tandem
ReadiUse™ TCEP removal solution
ReadiUse™ WST-8 *50 mM aqueous solution*
ReadiUse™ Rapid Luminometric ATP Assay Kit
ReadiUse™ PE [R-Phycoerythrin] *Ammonium Sulfate-Free*
ReadiUse™ CL-APC [Cross linked-Allophycocyanin] *Ammonium Sulfate-Free*
ReadiUse™ Preactivated PE-iFluor® 594 Tandem
ReadiUse™ Cell Detaching Buffer
ReadiUse™ DRAQ5 Staining Solution *5 mM in Water*
ReadiUse™ Staurosporine * 1 mM DMSO stock solution*
ReadiUse™ Bio-Gel P-6 spin column
ReadiUse™ bacterial cell lysis buffer *5X*
ReadiUse™ 10% Triton X-100 *Hydrogen Peroxide-and Carbonyl-Free*
ReadiUse™ Preactivated PE-iFluor® 700 Tandem
ReadiUse™ dNTP Mix *10 mM*
ReadiUse™ Viral RNA Lysis Buffer
ReadiUse™ Tyramide (TSA)/Styramide (PSA) Optimized Reaction Buffer
ReadiUse™ Preactivated PerCP
ReadiUse™ Preactivated PerCP-Cy5.5 Tandem
ReadiUse™ Preactivated PE-iFluor® 660 Tandem
ReadiUse™ 10KD Spin Filter
ReadiUse™ Preactivated APC-iFluor® 800 Tandem
ReadiUse™ 1 Kb Plus DNA Ladder
ReadiUse™ GeneRuler 1 kb DNA Ladder
ReadiUse™ 100 bp DNA Ladder
ReadiUse™ ddNTP Terminator Mix *10 mM*
ReadiUse™ dNTP Mix Set *10 mM PCR Grade*
ReadiUse™ Stayright™ Purple *HRP Chromogen Premixed with Hydrogen Peroxide*
ReadiUse™ Disposable PD-10 Desalting Column
ReadiUse™ 6-Color Human TBNK Antibody Kit *Dry Reagent Format*
ReadiUse™ MTS Reagent *5 mM aqueous solution*
ReadiUse™ Preactivated PE-Texas Red Maleimide
ReadiUse™ Preactivated PE-Cy5 Maleimide
ReadiUse™ Preactivated PE-Cy5.5 Maleimide
ReadiUse™ Preactivated PE-Cy7 Maleimide
ReadiUse™ Preactivated APC-AF700 Maleimide
ReadiUse™ Preactivated APC-Cy5.5 Maleimide
ReadiUse™ Preactivated APC-Cy7 Maleimide
ReadiUse™ Preactivated PerCP-Cy5.5 Maleimide
ReadiUse™ Preactivated PerCP-Cy7 Maleimide
ReadiUse™ PCR Reaction Buffer
ReadiUse™ Universal Kinase Reaction Stopping Buffer
ReadiUse™ Yeast Cell Lysis Buffer *5X*
ReadiUse™ ATP Reference Standard *10 mM Aqueous Solution*
Show More (58)

OverviewpdfSDSpdfProtocol


See also: PE and APC
Correction Factor (280 nm)
0.195
Extinction coefficient (cm -1 M -1)
730000
Excitation (nm)
651
Emission (nm)
660
ReadiUse™ Preactivated APC Maleimide is prepared by reacting highly purified allophycocyanin (APC) with SMCC. The NHS group of SMCC reacts with the lysine groups of APC, leaving maleimide groups available to react with free sulfhydryl groups on proteins to be conjugated. ReadiUse™ Preactivated APC Maleimide is highly purified to completely remove the unreacted SMCC, and lyophilized to powder. It is ready to use and will conjugate without further preparation upon mixing with sulfhydryl-containing target molecules such as reduced IgGs. The activated allophycocyanin can be easily conjugated to antibodies and other proteins without the use of added chemical crosslinking agents. These highly purified phycobiliproteins maintain their spectral characteristics of APC.

Example protocol


SAMPLE EXPERIMENTAL PROTOCOL

Reduction of Antibody
  1. Prepare a fresh solution of 1.0 M DTT (15.4 mg/100 µL) in distilled water. Antibody reduction can be carried out in different buffers, such as MES, phosphate, or TRIS (pH 6 to 8). For best results, antibody solutions should be >2 mg/mL. If less than 2 mg/mL, the antibody should be concentrated.
  2. Add 2 µL of 1.0 M DTT stock per 100 µL of antibody solution, and mix well. Let the antibody solution stand at room temperature for 30 minutes without additional mixing to minimize the reoxidation of cysteines.
  3. Purify the reduced antibody using a desalting column (Cat No. 60500) pre-equilibrated with 50 mM MES buffer (pH 6.0-6.5) and 2 mM EDTA.
  4. Measure the antibody concentration using a Nanodrop. (Con. (mg/mL) = A280nm/1.4).
    Note     Reduced antibodies are typically unstable. It is best to run the conjugation reaction immediately following purification.
     

Conjugate with ReadiUse™ Preactivated APC Maleimide
  1. Reconstitute ReadiUse™ Preactivated APC Maleimide in ddH2O to make a 10 mg/mL solution. For Cat No. 2567 (1 mg) reconstitute in 100 µL of ddH2O. If using Cat No. 2568 (5 mg), reconstitute in 500 µL of ddH2O. Reconstituted ReadiUse™ Preactivated APC Maleimide solutions are stable at 4 °C for up to one month, protected from light.
  2. Add the reduced antibody directly to the solution of ReadiUse™ Preactivated APC at a ratio of 130 µg APC/100 µg of reduced antibody.
  3. Rotate the mixture for 60 to 120 minutes at room temperature.
  4. Block any free sulfhydryl groups on the antibody. Prepare a fresh solution of 10 mg/mL N-Ethylmaleimide (NEM) in DMSO and add 3.4 µL per mg of antibody. Rotate for 20 minutes at room temperature. 

Conjugate Purification
  1. Purify the antibody/APC conjugate solution using size exclusion chromatography.
    Note     Typically the antibody/APC conjugate can be stored at 2-8 °C, protected from light, for up to 6 months. The best storage conditions for any particular conjugate must be determined by experimentation and depends on the stability of the antibody.
     

Spectrum


Open in Advanced Spectrum Viewer
spectrum

Spectral properties

Correction Factor (280 nm)0.195
Extinction coefficient (cm -1 M -1)730000
Excitation (nm)651
Emission (nm)660

Product Family


NameExcitation (nm)Emission (nm)Extinction coefficient (cm -1 M -1)Correction Factor (280 nm)
ReadiUse™ Preactivated PE Maleimide [Activated R-Phycoerythrin]56557419600000.175
ReadiUse™ Preactivated PerCP Maleimide4776784060000.22

Images


References


View all 13 references: Citation Explorer
Magnetic particles encoding a suspension probe for ultra-sensitive and quantitative determination of atrazine.
Authors: Zhao, Zhigao and Dou, Xiaowen and Luo, Jiaoyang and Jin, Meiqi and Qin, Jiaan and Wang, Changjian and Yang, Shihai and Yang, Meihua
Journal: Journal of pharmaceutical and biomedical analysis (2021): 113868
Non-oxidative band-3 clustering agents cause the externalization of phosphatidylserine on erythrocyte surfaces by a calcium-independent mechanism.
Authors: Koshkaryev, Alexander and Livshits, Leonid and Pajic-Lijakovic, Ivana and Gural, Alexander and Barshtein, Gregory and Yedgar, Saul
Journal: Biochimica et biophysica acta. Biomembranes (2020): 183231
Leukocyte-Derived Extracellular Vesicles in Blood with and without EpCAM Enrichment.
Authors: Nanou, Afroditi and Zeune, Leonie L and Terstappen, Leon W M M
Journal: Cells (2019)
Exogenous IL-9 Ameliorates Experimental Autoimmune Myasthenia Gravis Symptoms in Rats.
Authors: Yao, Xiuhua and Zhao, Jiarui and Kong, Qingfei and Xie, Xiaoli and Wang, Jinghua and Sun, Bo and Xu, Lixia and Mu, Lili and Li, Hulun
Journal: Immunological investigations (2018): 712-724
Non-invasive dual fluorescence in vivo imaging for detection of macrophage infiltration and matrix metalloproteinase (MMP) activity in inflammatory arthritic joints.
Authors: Cho, Hongsik and Bhatti, Fazal-Ur-Rehman and Yoon, Tae Won and Hasty, Karen A and Stuart, John M and Yi, Ae-Kyung
Journal: Biomedical optics express (2016): 1842-52
Monitoring genotoxicity in patients receiving chemotherapy for cancer: application of the PIG-A assay.
Authors: Horibata, Katsuyoshi and Ukai, Akiko and Ishikawa, Shigeo and Sugano, Ayako and Honma, Masamitsu
Journal: Mutation research. Genetic toxicology and environmental mutagenesis (2016): 20-6
A high-throughput neutralizing assay for antibodies and sera against hepatitis E virus.
Authors: Cai, Wei and Tang, Zi-Min and Wen, Gui-Ping and Wang, Si-Ling and Ji, Wen-Fang and Yang, Min and Ying, Dong and Zheng, Zi-Zheng and Xia, Ning-Shao
Journal: Scientific reports (2016): 25141
Endothelial activation and apoptosis mediated by neutrophil-dependent interleukin 6 trans-signalling: a novel target for systemic sclerosis?
Authors: Barnes, Theresa C and Spiller, David G and Anderson, Marina E and Edwards, Steven W and Moots, Robert J
Journal: Annals of the rheumatic diseases (2011): 366-72
A new procedure for the quantitative assessment of p-glycoprotein efflux pump associated with human T lymphocytes.
Authors: Vélez, Rosa and Sánchez, María del C and Lopez, Pablo and Yamamura, Yasuhiro
Journal: Ethnicity & disease (2008): S2-75-80
Dextramers: new generation of fluorescent MHC class I/peptide multimers for visualization of antigen-specific CD8+ T cells.
Authors: Batard, Pascal and Peterson, Daniel A and Devêvre, Estelle and Guillaume, Philippe and Cerottini, Jean-Charles and Rimoldi, Donata and Speiser, Daniel E and Winther, Lars and Romero, Pedro
Journal: Journal of immunological methods (2006): 136-48